Patents by Inventor Lynn M. Schiavoni

Lynn M. Schiavoni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assay for analytes using multiple receptors
    Patent number: 10088490
    Abstract: A method for determining an analyte in a sample suspected of containing the analyte comprises providing in combination a medium, the sample, and two or more different receptors. Each different receptor binds to at least two different epitopic sites. One of the epitopic sites is a common binding site and one of the epitopic sites is non-common binding site. The non-common epitopic sites are different for each different receptor. The receptors exhibit mono-molecular binding. The medium is incubated under conditions for binding of the receptors to the epitopic sites. The medium is examined for the presence and/or amount of complexes comprising the epitopic sites and the receptors. The presence and/or amount of the complexes indicate the presence and/or amount of the analyte in the sample.
    Type: Grant
    Filed: August 20, 2010
    Date of Patent: October 2, 2018
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: Sandra A. Lewisch, Lynn M. Schiavoni, William D. Bedzyk
  • ASSAY FOR ANALYTES USING MULTIPLE RECEPTORS
    Publication number: 20120045847
    Abstract: A method for determining an analyte in a sample suspected of containing the analyte comprises providing in combination a medium, the sample, and two or more different receptors. Each different receptor binds to at least two different epitopic sites. One of the epitopic sites is a common binding site and one of the epitopic sites is non-common binding site. The non-common epitopic sites are different for each different receptor. The receptors exhibit mono-molecular binding. The medium is incubated under conditions for binding of the receptors to the epitopic sites. The medium is examined for the presence and/or amount of complexes comprising the epitopic sites and the receptors. The presence and/or amount of the complexes indicate the presence and/or amount of the analyte in the sample.
    Type: Application
    Filed: August 20, 2010
    Publication date: February 23, 2012
    Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.
    Inventors: Sandra A. Lewisch, Lynn M. Schiavoni, William D. Bedzyk